Xeljanz 5 MG tablet UU 60S
Ended Awarded
- Contract number
- SPE2DB25FFBEL
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $63,320
Award facts
- Contract value 100% obligated
- $63,320.06 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $63,320.06 delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Xeljanz 5 mg tablets (60-count unit of use packaging). This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of September 29, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion prime contract vehicle designated SPE2DX and running through December 2026 that enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical federal vendor for military and veteran healthcare systems through the Defense Logistics Agency's Medical Supply Chain. The company has demonstrated substantial capability in fulfilling federal pharmaceutical procurement requirements through its extensive portfolio of competitively awarded contracts covering brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains. The DLA is planning to establish Pharmaceutical Prime Vendor Global Program Generation V contracts with multiple regional awards anticipated to involve at least three different contractors, positioning AmerisourceBergen as a key supplier within this strategic framework serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Quick answers
Who was awarded contract SPE2DB25FFBEL?
SPE2DB25FFBEL was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 26, 2025.
How much is contract SPE2DB25FFBEL worth?
The government has obligated $63,320 on SPE2DB25FFBEL.
Is contract SPE2DB25FFBEL an order under another contract?
Yes. SPE2DB25FFBEL is a delivery order under SPE2DB24D1021, an indefinite delivery contract.
Was contract SPE2DB25FFBEL competed?
The extent of competition for SPE2DB25FFBEL was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award